<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Laxatives and Stool Softeners</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Laxatives and Stool Softeners</md:title>
    <md:content-id>m00423</md:content-id>
    <md:uuid>bf10af94-9889-4b7b-8f6d-f5e903d9ac61</md:uuid>
  </metadata>
  <content>
    <section class="learning-objectives" id="sect-00001">
    <title>Learning Outcomes</title>
    <para id="para-00001">By the end of this section, you should be able to:</para>
    <list id="list-00001">
    <item>Identify the characteristics of laxative and stool-softener drugs used to treat gastrointestinal disorders.</item>
    <item>Explain the indications, actions, adverse reactions, and interactions of laxative and stool-softener drugs used to treat gastrointestinal disorders.</item>
    <item>Describe nursing implications of laxative and stool-softener drugs used to treat gastrointestinal disorders.</item>
    <item>Explain the client education related to laxative and stool-softener drugs used to treat gastrointestinal disorders.</item>
    </list>
    </section>
    <para id="para-00002">Constipation is an unpleasant symptom or disorder that results in difficult stool evacuation or irregular and inconsistent stool passage, with common complaints like straining, incomplete or difficulty passing stools, or not defecating for a prolonged time. Stool may be small, round, hard, and lumpy when evacuated. Occasional constipation results in a feeling of fullness and wide-ranging discomfort. It often results from low fiber intake, dehydration, and a sedentary lifestyle. Certain medications can also promote constipation, such as anticholinergics and opioids.</para>
    <para id="para-00003">Treatment involves increasing fiber intake, staying hydrated, and being physically active. Laxatives and stool softeners can help if constipation persists, but they should be used briefly to avoid dependency.</para>
    <section id="sect-00002">
    <section id="sect-00003">
    <title>Bulk-Forming Laxatives</title>
    <para id="para-00004"><term class="no-emphasis" id="term-00001">Bulk-forming</term> <term id="term-00002">laxatives</term> relieve constipation within 24–72 hours by supplying the colon with an increase in dietary fiber. However, it is imperative that these products are taken with an adequate amount of water. If these products are not taken with enough water, it may result in worsening constipation as well as esophageal and/or stomach obstruction. Bulk-forming laxatives are commonly marketed over the counter as a fiber supplement to promote regularity and improve cardiovascular and digestive health. Bulk-forming laxatives should not be used in clients with symptoms of acute appendicitis, esophageal stricture or perforation, GI obstruction, or ileus. See <link target-id="table-00001" document="m00423"/> for adult dosing of these drugs.</para>
    <section id="sect-00004">
    <title>Psyllium</title>
    <para id="para-00005">Psyllium is an oral bulk-producing laxative that promotes natural elimination by absorbing water into its soluble fiber, softening feces and increasing stool bulk. It is considered safe and can help with occasional and chronic constipation relief. Psyllium supports digestive health, helps to maintain healthy glycemic control, promotes a healthy heart with cholesterol reduction, and promotes a healthy weight by reducing hunger (Proctor &amp; Gamble, 2022). It is available over the counter in granules or powder to mix with water or juice. It is crucial to drink enough fluids to prevent complications like obstruction. Psyllium is also available as a wafer, but adequate water intake is essential to avoid choking and ensure its effectiveness. See <link target-id="table-00002" document="m00423"/> for additional information.</para>
    </section>
    <section id="sect-00005">
    <title>Methylcellulose</title>
    <para id="para-00006">Another bulk-forming laxative, methylcellulose, is often used for both constipation and diarrhea for adults and children over age 3. Methylcellulose has also been used to promote regularity in irritable bowel syndrome (IBS) when taken as directed in capsule or powder suspension. As with its prototype, psyllium, it may take up to 3 days to work. Taking methylcellulose with several glasses of water will increase its effectiveness.</para>
    </section>
    <section id="sect-00006">
    <title>Calcium Polycarbophil</title>
    <para id="para-00007">Calcium polycarbophil restores a balanced moisture level in the colon to form solid soft stool in cases of constipation or diarrhea. It promotes GI motility and regularity in conditions such as acute bowel syndrome, irritable bowel syndrome, and diverticulosis or after small-bowel surgery. Available in tablet and chewable forms, it should be taken with at least 8 ounces of water or juice to prevent choking and ensure its effectiveness.</para>
    <note class="link-to-learning" id="note-00001">
      <title>Are Bulk-Forming/Fiber Supplements Safe to Take Daily?</title>
      <para id="para-00008">Bulk-forming laxatives are often used as dietary supplements for regularity and gastrointestinal health. <link url="https://openstax.org/r/mayoclinicorghli">This Mayo Clinic post</link> explores the benefits of taking bulk-forming laxatives daily.</para>
    </note>
    </section>
    </section>
    <section id="sect-00007">
    <title>Lubricant Laxatives</title>
    <para id="para-00009">The goal of <emphasis effect="italics">lubricant laxatives</emphasis> is to soften stool and lubricate the intestinal wall, making defecation easier and preventing straining. The onset of action for lubricant laxatives is typically 8–48 hours, depending on the client’s normal gastrointestinal transit time. Lubricant laxatives generally do not produce increased peristatic activity that causes abdominal cramping and spasms. These laxatives are often preferred by pregnant clients and older adults. If used frequently, they may interfere with the absorption of fat-soluble vitamins (A, D, E, and K).</para>
    <section id="sect-00008">
    <title>Mineral Oil</title>
    <para id="para-00010">Mineral oil serves as a lubricant laxative for constipation or fecal impaction and facilitates the elimination of barium residue in post-GI studies. It is available in various forms, including oral liquid and rectal enema. Mineral oil is not recommended for children under age 6 or individuals with swallowing issues or incapacitation due to the risk of lipid pneumonia if aspirated. Mineral-oil enemas act fast and should be administered with care to prevent complications like bowel perforation. See <link target-id="table-00001" document="m00423"/>.</para>
    </section>
    </section>
    <section id="sect-00009">
    <title>Stimulant Laxatives</title>
    <para id="para-00011">Stimulant laxatives intensify intestinal peristalsis and increase the volume of intestinal water to relieve acute constipation that may be caused by high-dose opioid use. Stimulant laxatives are widely used and abused by the public. Approximately 40% of chronic constipation sufferers self-medicate with laxatives (Rao &amp; Brenner, 2021). They are commonly used as part of bowel prep before colon procedures or surgeries, but are sometimes misused to eliminate calories in an attempt to lose or maintain weight. However, such abuse can result in electrolyte imbalances, dehydration, and potential harm to the gastrointestinal system's neuromuscular functions. Stimulant laxatives may also lead to anal leakage, causing discomfort and affecting a client’s confidence when leaving their home. See <link target-id="table-00001" document="m00423"/>.</para>
    <section id="sect-00010">
    <title>Bisacodyl</title>
    <para id="para-00012">Bisacodyl is a stimulant laxative that directly irritates the sensory nerve endings in the smooth muscle of the intestine that induces peristalsis. Bisacodyl also stimulates an increased volume of water and electrolytes in the intestine. The action is directly responsible for the adverse effects of abdominal cramping, diarrhea, fluid, and electrolyte imbalances. Bisacodyl is typically used on a short-term basis to relieve constipation and should be taken as directed to minimize these side effects and complications.</para>
    <note class="clinical-tip" id="note-00002">
    <title>Administering a Bisacodyl Suppository</title>
    <list list-type="bulleted" id="list-00002">
    <item>If the suppository feels soft in the foil package, return the package to the refrigerator to harden before removing the wrapper.</item>
    <item>Assist the client to a comfortable left side–lying position with their right knee raised to their chest.</item>
    <item>With a gloved hand, use a finger to insert the pointed end of the suppository about 1 inch (2.5 cm) past the rectal sphincter.</item>
    <item>Have the client hold the suppository in place as long as possible. Gently holding the client’s buttocks together may help the client retain the suppository as long as possible, for up to 20 minutes.</item>
    <item>Assist the client with toileting.</item>
    <item>Remove gloves and wash hands thoroughly.</item>
    </list>
    </note>
    <note class="clinical-tip" id="note-00003">
    <title>Administering a Bisacodyl Enema</title>
    <list list-type="bulleted" id="list-00003">
    <item>Shake the enema bottle well.</item>
    <item>Assist the client to a comfortable left side–lying position with their right knee raised to their chest.</item>
    <item>With a gloved hand, remove the protective shield and gently insert the enema tip into the rectum with the tip pointed toward the navel.</item>
    <item>Gently squeeze the bottle until the contents are emptied into the rectum.</item>
    <item>Remove the enema bottle from the rectum.</item>
    <item>Have the client hold the enema contents in place as long as possible, for about 10 minutes. Gently holding the client’s buttocks together may help the client retain the contents.</item>
    <item>Assist the client with toileting.</item>
    <item>Remove gloves and wash hands thoroughly.</item>
    </list>
    </note>
    </section>
    <section id="sect-00011">
    <title>Castor Oil</title>
    <para id="para-00013">Castor oil is an oral stimulant laxative used for constipation or as a bowel prep before a procedure. Castor oil is produced from the castor bean. When castor oil is in the intestine, lipase breaks down the castor oil into ricinoleic acid, a fatty acid that directly stimulates peristaltic activity of the colon to produce a bowel movement in 6–12 hours.</para>
    <para id="para-00014">Castor oil is a liquid often mixed in fruit juice to mask the taste. Castor oil is contraindicated in pregnancy due to risk of inducing uterine contractions.</para>
    </section>
    <section id="sect-00012">
    <title>Senna</title>
    <para id="para-00015">Senna is a laxative that converts senna glycosides to active aglycone in the colon to soften feces and stimulate peristalsis, for acute constipation and preprocedural bowel evacuation. Senna is available in tablets and as a syrup. Senna is also available in teas that are marketed for constipation relief.</para>
    </section>
    </section>
    <section id="sect-00013">
    <title>Saline Laxatives</title>
    <para id="para-00016"><term class="no-emphasis" id="term-00003">Saline laxatives</term> are hyperosmotic oral solutions that retain water in the intestine to increase the bulk of the stool. Sometimes called “salts,” these laxatives are used when there is a need for a quick emptying of the lower bowel or intestine. The salts are absorbed, causing osmotic action to draw water into the intestinal lumen of the colon and causing the fecal mass to increase in size, or “swell.” The increase in bulk softens the stool for easier evacuation while also stretching the intestinal wall, causing peristaltic movement. Because the hypertonic solution offers a rapid emptying of the bowels, saline laxatives are not recommended for long-term or repeated use (Mayo Foundation for Medical Education and Research, 2023a). See <link target-id="table-00001" document="m00423"/>.</para>
    <section id="sect-00014">
    <title>Magnesium Citrate</title>
    <para id="para-00017">Magnesium citrate, often referred to as <emphasis effect="italics">citrate of magnesia</emphasis> or <emphasis effect="italics">mag citrate</emphasis>, is a hyperosmotic saline cathartic laxative available as an oral solution. Magnesium citrate evacuates bowels before surgical or diagnostic procedures within 3–6 hours. Magnesium citrate is best given on an empty stomach with 240 milliliters (mL) of water. The solution is more palatable if chilled. Once opened, the effectiveness of magnesium citrate decreases.</para>
    <para id="para-00018">Available in liquid or tablet form over the counter, magnesium citrate should be used as directed by the health care provider or per the instructions on the product label to avoid potential side effects or complications. It typically produces a bowel movement within a few hours of ingestion and is known for its effectiveness in promoting bowel regularity when needed.</para>
    </section>
    <section id="sect-00015">
    <title>Polyethylene Glycol</title>
    <para id="para-00019">Polyethylene glycol is an osmotic laxative that is used for occasional and chronic constipation. This medication causes water to be drawn into the stool for easier evacuation. While it may take 2–4 days to produce results for chronic and occasional constipation, larger doses of polyethylene glycol are often used for bowel preparation before diagnostic and/or surgical procedures.</para>
    <para id="para-00020">Available as a powder, a single heaping tablespoon of polyethylene glycol is reconstituted in 8 ounces of various beverages such as water, juice, soda, coffee, or tea. Stirring helps the powder dissolve, and the mixture should be consumed immediately. Typically, polyethylene glycol is taken once daily for up to 14 days, following the health care provider guidance for proper use and dosage.</para>
    </section>
    </section>
    <section id="sect-00016">
    <title>Miscellaneous Laxatives</title>
    <para id="para-00021">Miscellaneous laxatives are a group of drugs that do not fit into the more common categories of laxatives. These miscellaneous laxatives have different mechanisms of action and are used for the specific purpose of relieving constipation. See <link target-id="table-00001" document="m00423"/> for adult dosing of these drugs.</para>
    <section id="sect-00017">
    <title>Linaclotide</title>
    <para id="para-00022">Linaclotide is classified as an accelerant of GI transit or guanylate cyclase-C agonist. Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation, to improve bowel function, to eliminate constipation, and to decrease bowel irritation. Linaclotide is contraindicated if there is a suspicion of GI obstruction. If severe diarrhea occurs, linaclotide should be stopped and the provider contacted.</para>
    </section>
    <section id="sect-00018">
    <title>Sorbitol</title>
    <para id="para-00023">Sorbitol is a sugar alcohol or polyol that is commonly used as a sugar substitute in various sugar-free and "diet" food products. It is a sweet-tasting substance with approximately 60% of the sweetness of sucrose (table sugar). When taken orally, sorbitol has a laxative effect because it draws water into the intestines, softening the stool and promoting bowel movements. It is sometimes used to relieve constipation, especially in situations where a mild, osmotic laxative is needed.</para>
    </section>
    </section>
    <section id="sect-00019">
    <title>Stool Softeners</title>
    <para id="para-00024"><term id="term-00004">Stool softeners</term> are a type of laxative medication that helps to alleviate constipation by softening the stool, making it easier to pass. They work by increasing the water content of the stool, which helps to prevent and relieve constipation-related discomfort and straining during bowel movements. See drug emphasis <link target-id="table-00001" document="m00423"/>.</para>
    <section id="sect-00020">
    <title>Docusate Sodium and Docusate Calcium</title>
    <para id="para-00025">Docusate sodium and docusate calcium are stool softeners often called surfactant laxatives. Docusate sodium and docusate calcium act like a detergent in the intestine, with anionic emulsifying and wetting properties to lower the surface tension of stool to allow penetration by water for easier defecation. Docusate sodium is available in tablets, capsules, and syrups. Docusate calcium is available as a capsule. Docusate is used prophylactically for clients at risk for constipation or fecal impaction who should avoid straining, such as postoperatively or after a myocardial infarction.</para>
    <para id="para-00026">Docusate can be administered orally or rectally. Oral administration should be given with a full 8-ounce glass of water. The client should be encouraged to drink adequate fluid throughout the day. Oral solution (but not syrup) may be mixed with milk, fruit juice, or infant formula. Syrups are stored in an airtight bottle at room temperature. Rectal docusate is added to a microenema and administered via the rectum as an enema. Therapeutic effectiveness is achieved within 1–3 days.</para>
    <para id="para-00027"><link target-id="table-00001" document="m00423"/> lists common laxatives and stool softeners with typical routes and dosing for adult clients.</para>
          <table class="vertically-tight" id="table-00001">
         <tgroup cols="2">
          <colspec colnum="1" colname="c1" colwidth="1*"/>
          <colspec colnum="2" colname="c2" colwidth="2*"/>
         <thead>
          <row>
          <entry valign="top" align="center"><span class="blue-text">Drug</span></entry>
          <entry valign="top" align="center"><span class="blue-text">Routes and Dosage Ranges</span></entry>
          </row>
          </thead>
          <tbody>
          <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Bulk Forming Laxatives</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00005">Psyllium</term><newline/>
    (<term class="no-emphasis" id="term-00006">Fiberall, Konysl</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (powder):</emphasis> 1 rounded tablespoon (12 grams) 3 times daily.<newline/>
    <emphasis effect="italics">Oral (granules):</emphasis> 1 teaspoon (6 grams) 1–3 times daily.<newline/>
    <emphasis effect="italics">Oral (1.8-gram capsule):</emphasis> 5 capsules with at least 8 ounces of liquid, up to 3 times daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00007">Methycellulose</term><newline/>
    (<term class="no-emphasis" id="term-00008">Citrucil</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral: </emphasis>Start with 2 500-mg caplets, increased as needed up to 6 times a day. Do not exceed 12 caplets per day.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00009">Calcium polycarbophil</term><newline/>
    (<term class="no-emphasis" id="term-00010">FiberCon</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral:</emphasis> 2 625-mg tablets 1–4 times per day.</entry>
    </row>
    <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Lubricant Laxatives</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00011">Mineral Oil</term></entry>
    <entry><emphasis effect="italics">Oral (liquid):</emphasis> 1–2 tablespoons at bedtime.<newline/>
    <emphasis effect="italics">Rectal (enema):</emphasis> One bottle (4.5 fl. oz.) daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Stimulant Laxatives</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center">
    <term class="no-emphasis" id="term-00012">Bisacodyl Pr</term><newline/>
    (<term class="no-emphasis" id="term-00013">Dulcolax, Correctol</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (5-mg tablet):</emphasis> 1–3 tablets in a single dose daily.<newline/>
    <emphasis effect="italics">Rectal (suppository):</emphasis> 10 mg (1 suppository) once daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center">
    <term class="no-emphasis" id="term-00014">Castor oil</term><newline/>
    (<term class="no-emphasis" id="term-00015">Emulsoil</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (liquid):</emphasis> 15–60 mL in a single daily dose.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00016">Senna</term><newline/>
    (<term class="no-emphasis" id="term-00017">Senokot</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (tablet):</emphasis> 1 tablet once or twice daily.<newline/>
    <emphasis effect="italics">Oral (liquid):</emphasis> 10–30 mL up to 2 times daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Saline Laxatives</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00018">Magnesium citrate</term><newline/>
    (<term class="no-emphasis" id="term-00019">Citroma</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (liquid):</emphasis> 6.5–10 fl. oz. daily.<newline/>
    <emphasis effect="italics">Maximum dose:</emphasis> 10 fl. oz. in 24 hours.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00020">Polyethylene glycol</term><newline/>
    (<term class="no-emphasis" id="term-00021">Miralax</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral (powder): </emphasis>17 grams of powder dissolved in 4–8 ounces of beverage daily. Do not use for more than 7 days.</entry>
    </row>
    <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Miscellaneous Laxatives</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00022">Linaclotide</term><newline/>
    (<term class="no-emphasis" id="term-00023">Linzess</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">For IBS with constipation, oral:</emphasis> 290-mcg tablet once daily.<newline/>
    <emphasis effect="italics">For chronic idiopathic constipation, oral: </emphasis>145-mcg tablet once daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00024">Sorbitol</term><newline/>
    (<term class="no-emphasis" id="term-00025">Arlex</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Rectal (enema):</emphasis> 120mL daily as needed.</entry>
    </row>
    <row>
    <entry valign="middle" align="center" namest="c1" nameend="c2"><span class="blue-text"><emphasis effect="bold">Stool Softeners</emphasis></span></entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00026">Docusate sodium</term><newline/>
    (<term class="no-emphasis" id="term-00027">Colace</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral: </emphasis>1–3 100-mg softgels daily.</entry>
    </row>
    <row>
    <entry valign="middle" align="center"><term class="no-emphasis" id="term-00028">Docusate calcium</term><newline/>
    (<term class="no-emphasis" id="term-00029">Surfak</term>)</entry>
    <entry valign="middle" align="left"><emphasis effect="italics">Oral: </emphasis>240 mg softgel once daily for 2–3 days or until bowel movements are normal.</entry>
    </row>
    </tbody>
    </tgroup>
    <caption>Drug Emphasis Table: Laxatives and Stool Softeners (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
    </table>
    </section>
    </section>
    <section id="sect-00021">
    <title>Adverse Effects and Contraindications</title>
    <para id="para-00028">Typical adverse effects of laxatives and stool softeners include abdominal cramping, diarrhea, electrolyte imbalances (particularly sodium and potassium), dehydration, rectal irritation, and gas and bloating.</para>
    <para id="para-00029">Contraindications for laxatives and stool softeners include hypersentivitity to the drug or any of its components, intestinal blockage, appendicitis, and certain medical conditions such as Crohn’s disease or ulcerative colitis.</para>
    <para id="para-00030">Laxatives should be used cautiously, as over time the body can become reliant on the drug to have bowel movements, leading to a condition known as laxative dependency. This can make it harder to have regular bowel movements without the use of laxatives.</para>
    <para id="para-00031"><link target-id="table-00002" document="m00423"/> is a prototype table for laxatives and stool softeners featuring psyllium. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
    <table class="vertically-tight" id="table-00002">
    <tgroup cols="2">
    <colspec colnum="1" colname="col1" colwidth="1*"/>
    <colspec colnum="2" colname="col2" colwidth="1*"/>
    <tbody>
    <row>
    <entry valign="top">
    <emphasis effect="bold"><span class="blue-text">Drug Class</span></emphasis><newline/>
    Bulk-forming laxative<newline count="2"/>
    <emphasis effect="bold"><span class="blue-text">Mechanism of Action</span></emphasis><newline/>
    Adds bulk to stool through water absorption, which promotes peristalsis and natural elimination</entry>
    <entry valign="top">
    <emphasis effect="bold"><span class="blue-text">Drug Dosage</span></emphasis><newline/>
    <emphasis effect="italics">Oral (powder):</emphasis> 1 rounded tablespoon (12 grams) 3 times daily.<newline/>
    <emphasis effect="italics">Oral (granules):</emphasis> 1 teaspoon (6 grams) 1–3 times daily.<newline/>
    <emphasis effect="italics">Oral (1.8-gram capsule): </emphasis>5 capsules with at least 8 ounces of liquid, up to 3 times daily.<newline/></entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
    Short-term relief of occasional constipation and to promote regularity<newline count="2"/>
    <emphasis effect="bold"><span class="blue-text">Therapeutic Effects</span></emphasis><newline/>
    Bowel movement within 12–72 hours</entry>
    <entry valign="top"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
    No significant interactions<newline count="2"/>
    <emphasis effect="bold"><span class="blue-text">Food Interactions</span></emphasis><newline/>
    No significant interactions</entry>
    </row>
    <row>
    <entry valign="top">
    <emphasis effect="bold"><span class="blue-text">Adverse Effects</span></emphasis><newline/>
    Abdominal cramping<newline/>
    Diarrhea<newline/>
    Electrolyte imbalances<newline/>
    Rectal irritation<newline/>
    Gas/bloating</entry>
    <entry valign="top">
    <emphasis effect="bold"><span class="blue-text">Contraindications</span></emphasis><newline/>
    Hypersensitivity to the drug or any of its components<newline count="2"/>
    Caution:<newline/>
    Taking this product without adequate fluid may cause it to swell and block the throat or esophagus, causing choking; should not be taken if difficulty swallowing is present</entry>
    </row>
    </tbody>
    </tgroup>
    <caption>Drug Prototype Table: Psyllium (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
    </table>
    </section>
    <section id="sect-00022">
    <title>Nursing Implications</title>
    <para id="para-00032">The nurse should do the following for clients who are taking laxatives and stool softeners:</para>
    <list id="list-00004">
    <item>Prior to administering, assess the client’s medical history, current drug list, and allergies.</item>
    <item>Educate the client regarding laxative and stool effects, such as abdominal cramping, diarrhea, and rectal irriation.</item>
    <item>Assess client’s bowel habits including frequency, consistency, and ease of bowel movements. Monitor for changes with laxative and stool softener administration.</item>
    <item>Monitor electrolyte levels, particularly sodium and potassium, to detect abnormalities.</item>
    <item>Educate the client on lifestyle and dietary factors, such as increasing hydration and eating a healthy diet high in fiber to prevent constipation.</item>
    <item>Educate client that these drugs are for short-term use, and long-term use could result in dependence.</item>
    <item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
    </list>
    <note class="clinical-tip" id="note-00004">
    <title>Fecal Impaction and Bowel Obstruction</title>
    <para id="para-00033">When administering laxatives and stool softeners, the nurse should assess the client for signs and symptoms of fecal impaction and bowel obstruction, which include severe abdominal bloating and cramping, stool leakage or sudden watery diarrhea (around impaction), rectal bleeding, small semi-formed stools, severe abdominal pain, vomiting, loud sounds from the abdomen, and inability to pass flatulence.</para>
    </note>
    <note class="client-teaching" id="note-00005">
    <para id="para-00034"><emphasis effect="bold">The client taking a laxative or a stool softener should:</emphasis></para>
    <list list-type="bulleted" id="list-00005">
    <item>Increase their dietary intake of fiber and increase their fluid intake, if not contraindicated, to help reduce the risk of constipation.</item>
    <item>Report signs of muscle weakness, muscle cramps, fatigue, retrosternal pain, or numbness or tingling in the arms, legs and face, as these may be symptoms of serious adverse effects of the drugs.</item>
    </list>
    <para id="para-00035"><emphasis effect="bold">The client taking a laxative or a stool softener <emphasis effect="italics">should not:</emphasis></emphasis></para>
    <list list-type="bulleted" id="list-00006">
    <item>Take these drugs long term, as they may result in dependence.</item>
    </list>
    </note>
    <note class="unfolding-casestudy" id="note-00006">
    <para id="para-00036">Read the following clinical scenario to answer the questions that follow.</para>
    <para id="para-00037">Mae Belle Smith is a 24-year-old logistics manager. Her job requires long hours of sitting at a desk with few breaks for hydration. Mae Belle presented to her provider with complaints of severe abdominal pain and distention, and has not had a bowel movement in 6 days other than occasional leakage of scant amounts of liquid stool. Current medications include over-the-counter ibuprofen for occasional headaches.</para>
    <table class="vertically-tight" id="table-00003">
    <tgroup cols="3">
    <colspec colnum="1" colname="c1" colwidth="1*"/>
    <colspec colnum="2" colname="c2" colwidth="1*"/>
    <colspec colnum="3" colname="c3" colwidth="1*"/>
    <thead>
    <row>
    <entry valign="top" align="center" namest="c1" nameend="c2"><span class="blue-text">Vital Signs</span></entry>
    <entry valign="top" align="center"><span class="blue-text">Physical Examination</span></entry>
    </row>
    </thead>
    <tbody>
    <row>
    <entry valign="top"><emphasis effect="italics">Temperature:</emphasis></entry>
    <entry valign="top">99.5°F</entry>
    <entry valign="top" morerows="6">
    <list list-type="bulleted" id="list-00007">
    <item><emphasis effect="italics">Head, eyes, ears, nose, throat (HEENT):</emphasis> Within normal limits</item>
    <item><emphasis effect="italics">Cardiovascular:</emphasis> No jugular vein distention; S1, S2 noted</item>
    <item><emphasis effect="italics">Respiratory:</emphasis> Clear to auscultation bilateral all lung fields</item>
    <item><emphasis effect="italics">GI:</emphasis> Abdomen distended, lower abdomen firm, hypoactive bowel sounds in all 4 quadrants</item>
    <item><emphasis effect="italics">Neurological:</emphasis> Within normal limits</item>
    <item><emphasis effect="italics">Integumentary: </emphasis>No wounds noted; skin appropriate for age and ethnicity.</item></list></entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Blood pressure:</emphasis></entry>
    <entry valign="top">122/68 mm Hg</entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Heart rate:</emphasis></entry>
    <entry valign="top">93 beats/minute</entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Respiratory rate:</emphasis></entry>
    <entry valign="top">20 breaths/minute</entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Oxygen saturation:</emphasis></entry>
    <entry valign="top">99% on room air</entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Height:</emphasis></entry>
    <entry valign="top">5’7”</entry>
    </row>
    <row>
    <entry valign="top"><emphasis effect="italics">Weight:</emphasis></entry>
    <entry valign="top">56.8 kg</entry>
    </row>
    </tbody>
    </tgroup>
    </table>
    <exercise id="exer-00001"><problem id="prob-00001"><para id="para-00038"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_UCSQ1"/></para></problem></exercise>
    <exercise id="exer-00002"><problem id="prob-00002"><para id="para-00039"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_UCSQ2"/></para></problem></exercise>
    </note>
    </section>
    </section>
    <section class="chapter-summary" id="sect-00023">
    <para id="para-00040">This chapter discussed gastrointestinal disturbances such as nausea, vomiting, motion sickness, constipation, and diarrhea, which are often symptoms of an underlying condition. While treatment of the GI symptom is a priority, providers should explore the potential causes of the symptoms. Antiemetics, antidiarrheals, and laxatives may only be temporary solutions until the primary cause is discovered and treated.</para>
    <para id="para-00041">The text also noted that the GI system is vulnerable to fluid and electrolyte imbalances from GI disturbances as well as GI medications. Nurses must consistently assess GI status, the risk of dehydration, and electrolyte imbalances. Nurses should encourage clients to drink at least 2 liters of water a day, unless contraindicated, to promote a healthy GI tract and to optimize its proper functioning.</para>
    </section>
    <section class="review-questions" id="sect-00024">
          <title>Review Questions</title>
          <exercise id="exer-00003"><problem id="prob-00003"><para id="para-00042"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec02_RQ1"/></para></problem></exercise>
          <exercise id="exer-00004"><problem id="prob-00004"><para id="para-00043"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_RQ2"/></para></problem></exercise>
          <exercise id="exer-00005"><problem id="prob-00005"><para id="para-00044"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec01_RQ3"/></para></problem></exercise>
          <exercise id="exer-00006"><problem id="prob-00006"><para id="para-00045"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_RQ4"/></para></problem></exercise>
          <exercise id="exer-00007"><problem id="prob-00007"><para id="para-00046"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec01_RQ5"/></para></problem></exercise>
          <exercise id="exer-00008"><problem id="prob-00008"><para id="para-00047"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_RQ6"/></para></problem></exercise>
          <exercise id="exer-00009"><problem id="prob-00009"><para id="para-00048"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec02_RQ7"/></para></problem></exercise>
          <exercise id="exer-00010"><problem id="prob-00010"><para id="para-00049"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec03_RQ8"/></para></problem></exercise>
          <exercise id="exer-00011"><problem id="prob-00011"><para id="para-00050"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec01_RQ9"/></para></problem></exercise>
          <exercise id="exer-00012"><problem id="prob-00012"><para id="para-00051"><link class="os-embed" url="#exercise/PHAR_Ch30_Sec01_RQ10"/></para></problem></exercise>
          </section>
    <section class="references" id="sect-00025">
    <title>References</title>
    <para id="para-00052">DailyMed. (Updated November 29, 2022). <emphasis effect="italics">4718 Enema, mineral oil enema</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e51c852-9477-5cf5-e053-2a95a90a97db</para>
    <para id="para-00053">DailyMed. (Updated September 19, 2022). <emphasis effect="italics">Anti-diarrheal loperamide hcl, 2 mg caplets–loperamide hcl tablet. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3d4f789-d41c-4965-975b-5af743d7b8e3</para>
    <para id="para-00054">DailyMed. (Updated July 8, 2022). <emphasis effect="italics">Aprepitant capsule</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af9b6086-4bf2-472c-8740-4134eaaebace</para>
    <para id="para-00055">DailyMed. (Updated October 28, 2022). <emphasis effect="italics">Bisacodyl laxative enteric coated–bisacodyl tablet, coated. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f51f7e9-370e-4c19-8a45-0ae5ccfd4275</para>
    <para id="para-00056">DailyMed. (Updated August 17, 2022). <emphasis effect="italics">Best Choice fiber laxative–psyllium husk capsule. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92b46689-b5fc-41f4-91ac-535699900b39</para>
    <para id="para-00057">DailyMed. (Updated April 28, 2023). <emphasis effect="italics">BISAC-10 Bisacodyl stimulant laxative–bisacodyl suppository. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10816e1e-b00c-4f6f-a544-278635919d37</para>
    <para id="para-00058">DailyMed. (Updated March 29, 2023). <emphasis effect="italics">Bismuth subsalicylate 262 mg–bismuth subsalicylate tablet, chewable. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e40ffd8-1afa-43af-e054-00144ff8d46c</para>
    <para id="para-00059">DailyMed. (Updated July 18, 2022). <emphasis effect="italics">Calcium polycarbophil tablet, film coated. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4637e18-c65f-0e81-e053-2a95a90a2284</para>
    <para id="para-00060">DailyMed. (Updated December 5, 2022). <emphasis effect="italics">Castor oil liquid</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f20de8f2-3637-4485-8b80-0a12fd5e651c</para>
    <para id="para-00061">DailyMed. (Updated January 18, 2022<emphasis effect="italics">). Chlorpromazine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=432cd4ca-c728-48ff-beec-2485f5e02512</para>
    <para id="para-00062">DailyMed. (Updated March 17, 2022). <emphasis effect="italics">CVS mineral oil – mineral oil liquid. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d7402e1-524b-1084-e053-2a95a90ae3af</para>
    <para id="para-00063">DailyMed. (Updated September 13, 2023). <emphasis effect="italics">CVS senna laxative, sennosides liquid. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a5565b2-827f-4fcc-a835-d827f62da8f9</para>
    <para id="para-00064">DailyMed. (Updated October 18, 2019). <emphasis effect="italics">Diphenoxylate with atropine tablet. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73dc5f91-d562-44c5-a556-66c96ed1dd82</para>
    <para id="para-00065">DailyMed. (Updated April 10, 2020). <emphasis effect="italics">Docusate calcium 240 mg sodium free–docusate calcium capsule, liquid filled.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52139708-8a21-4fc5-b375-c6f9064cce22</para>
    <para id="para-00066">DailyMed. (Updated December 28, 2022<emphasis effect="italics">). Docusate sodium 100 mg two toned–docusate sodium capsule, liquid filled</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80092188-0517-4646-bd46-ab56c63bb354</para>
    <para id="para-00067">DailyMed. (Updated January 25, 2022). <emphasis effect="italics">Dronabinol capsule</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0409d82-a61e-4b9e-8717-ced299ccedb2</para>
    <para id="para-00068">DailyMed. (UpdatedJuly 24, 2022). <emphasis effect="italics">Genexa senna laxative–sennosides tablet. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b22e1f9a-20b9-4c8b-e053-2995a90ae1e2</para>
    <para id="para-00069">DailyMed. (Updated November 15, 2022). <emphasis effect="italics">Granisetron injection, solution. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dddc8714-383f-4bc5-a468-ae89dbc802b4</para>
    <para id="para-00070">DailyMed. (Updated February 4, 2010). <emphasis effect="italics">Hydroxyzine tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81f9d88f-c50b-4c6a-a25b-46fa162a503e</para>
    <para id="para-00071">DailyMed. (UpdatedDecember 06, 2022). <emphasis effect="italics">Konsyl Original Formula Psyllium Fiber – psyllium husk granule. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c876cf1-c2ab-4bdc-bb3e-ac2ce5863649</para>
    <para id="para-00072">DailyMed. (Updated june 12, 2023). <emphasis effect="italics">Linzess–linaclotide capsul, gelatin coated.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3</para>
    <para id="para-00073">DailyMed. (Updated September 12, 2023). <emphasis effect="italics">Lomotil–diphenoxylate hydrochloride and atropine sulfate tablet.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f170584a-1072-4fd7-b1dc-6756703483b9</para>
    <para id="para-00074">DailyMed. (Updated September 19, 2022). <emphasis effect="italics">Loperamide tablet. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3d4f789-d41c-4965-975b-5af743d7b8e3</para>
    <para id="para-00075">DailyMed. (Updated September 12, 2023). <emphasis effect="italics">Magnesium citrate–behealth magnesium citrate oral solution – cherry liquid.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0fa4b72-50a5-5c42-e053-2995a90a159a</para>
    <para id="para-00076">DailyMed. (Updated December 9, 2021). <emphasis effect="italics">Meclizine tablet, chewable.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf79ac74-017e-4fb4-85d3-4ea944080e89</para>
    <para id="para-00077">DailyMed. (Updated July 5, 2023). <emphasis effect="italics">Miralax–polyethylene glycol 3350 powder, for solution. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d69ce3d4-7ca4-4fe3-b49e-6655e48d6963</para>
    <para id="para-00078">DailyMed. (Updated September 15, 2023). <emphasis effect="italics">Mycapssa-octreotide capsule, delayed release.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62a5e1eb-b48e-4ea6-8781-f75e490b17e4</para>
    <para id="para-00079">DailyMed. (Updated June 26, 2023). <emphasis effect="italics">Octreotide acetate injection, solution.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=884e4287-a4d8-4a6e-8d99-dbe5e88875b9</para>
    <para id="para-00080">DailyMed. (Updated October 19, 2022). <emphasis effect="italics">Ondansetron injection.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59c4227a-90b6-4297-aacd-05bd097010c1</para>
    <para id="para-00081">DailyMed. (Updated November 7, 2022). <emphasis effect="italics">Pancreatinum–pancreatin granule.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=155903b0-3998-24c4-e054-00144ff8d46c</para>
    <para id="para-00082">DailyMed. (Updated October 27, 2021). <emphasis effect="italics">Polycarbophil tablet. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fabd7ec-228f-1565-e054-00144ff88e88</para>
    <para id="para-00083">DailyMed. (Updated February 8, 2023). <emphasis effect="italics">Polyethylene glycol powder, for solution.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29d821ff-389c-41fb-8a27-89bd3f022b82</para>
    <para id="para-00084">Daily Med. (2023). (Updated December 1, 2022). <emphasis effect="italics">Prochlorperazine edisylate injection</emphasis>. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=29f0e68d-4653-472d-bd86-e87a8e2cb529&amp;type=display</para>
    <para id="para-00085">DailyMed. (Updated July 11, 2022). <emphasis effect="italics">Promethazine hydrochloride injection.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13d9e59d-eadb-41d5-9f47-9c11a6efb31c</para>
    <para id="para-00086">DailyMed. (Updated October 27, 2020). <emphasis effect="italics">Psyllium fiber – psyllium husk powder</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afc52039-2370-4c21-b9c8-733ec009e881</para>
    <para id="para-00087">DailyMed. (Updated August 17, 2023). <emphasis effect="italics">Psyllium husk capsule.</emphasis> https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92b46689-b5fc-41f4-91ac-535699900b39</para>
    <para id="para-00088">DailyMed. (Updated August 19, 2020). <emphasis effect="italics">Rolapitant tablet</emphasis>. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a52896cd-4a98-49b8-82db-bf1985a64d97</para>
    <para id="para-00089">DailyMed. (Updated July 06, 2023). <emphasis effect="italics">Scopolamine transdermal system–scopolamine transdermal system patch, extended release. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb93bfad-3e37-4a27-92f6-f21703ae7bdf</para>
    <para id="para-00090">DailyMed. (Updated July 1, 2022). <emphasis effect="italics">Senna liquid. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a5565b2-827f-4fcc-a835-d827f62da8f9</para>
    <para id="para-00091">DailyMed. (Updated December 29, 2020). <emphasis effect="italics">Sorbitol Solution – sorbitol liquid. </emphasis>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4dd7a41-380e-d94b-e053-2a95a90ac34a</para>
    <para id="para-00092">Johns Hopkins Medicine. (2023). <emphasis effect="italics">Diarrhea</emphasis>. https://www.hopkinsmedicine.org/health/conditions-and-diseases/diarrhea</para>
    <para id="para-00093">Krishnamurthi, S., &amp; Macaron, C. (2022). <emphasis effect="italics">Management of acute chemotherapy-related diarrhea</emphasis>. UpToDate<emphasis effect="italics">. </emphasis>https://www.uptodate.com/contents/management-of-acute-chemotherapy-related-diarrhea</para>
    <para id="para-00094">Mayo Foundation for Medical Education and Research. (2023a). <emphasis effect="italics">Laxative (oral route).</emphasis> https://www.mayoclinic.org/drugs-supplements/laxative-oral-route/precautions/drg-20070683?p=1</para>
    <para id="para-00095">Mayo Foundation for Medical Education and Research. (2023b). <emphasis effect="italics">Phenothiazine (oral route, parenteral route, rectal route)—side effects</emphasis>. https://www.mayoclinic.org/drugs-supplements/phenothiazine-oral-route-parenteral-route-rectal-route/side-effects/drg-20070394</para>
    <para id="para-00096">National Library of Medicine. (2022). <emphasis effect="italics">Diphenoxylate and atropine</emphasis>. https://www.ncbi.nlm.nih.gov/books/NBK559300/</para>
    <para id="para-00097">Novartis. (2021).<emphasis effect="italics"> Highlights of prescribing information. </emphasis>https://www.novartis.com/us-en/sites/novartis_us/files/sandostatin_lar.pdf</para>
    <para id="para-00098">Proctor &amp; Gamble. (2022). <emphasis effect="italics">What is psyllium? The ultimate guide to psyllium husk. </emphasis>https://www.metamucil.com/en-us/articles/psyllium-fiber/what-is-psyllium-husk-and-what-are-its-benefits/</para>
    <para id="para-00099">Rao, S., &amp; Brenner, D. (2021). Efficacy and safety of over-the-counter therapies for chronic constipation: An updated systemic review. <emphasis effect="italics">American Journal of Gastroenterology, 161</emphasis>(6), 1156–1181. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191753/</para>
    </section>
    </content>
    <glossary>
    <definition id="def-00001"><term>laxatives</term> <meaning>medications used to treat constipation</meaning></definition>
    <definition id="def-00002"><term>stool softeners</term> <meaning>medications used to soften stools and ease defecation</meaning></definition>
    </glossary>
</document>